Expounding on Obesity

• Should 'South Park: The End of Obesity' Be Required Viewing? A new South Park episode tackles obesity, including the continuing demand for antiobesity medications. Yoni Freedhoff, MD, explains why it should be required viewing in medical school.
  Medscape Diabetes & Endocrinology, June 28, 2024
• 'Ozempic Burgers' Offer Indulgences to People With Obesity Nestlé recently announced they would sell food targeted for customers on anti-obesity medications. Yoni Freedhoff, MD, explains why this move should be celebrated.
  Medscape Diabetes & Endocrinology, June 04, 2024
• 'Stop Teaching' Kids It's Their Fault They're Fat New draft recommendations focus on lecturing children with obesity about diet while ignoring medications or surgery. Dr Yoni Freedhoff says this is another form of weight bias.
  Medscape Diabetes & Endocrinology, January 12, 2024
• 'Patients Fail' Despite Benefits of Sustained Weight Loss Obesity needs to be treated like every other chronic noncommunicable disease rather than as personal responsibility, contends Yoni Freedhoff, MD.
  Medscape Diabetes & Endocrinology, August 25, 2023
• 10 Ways Docs Sabotage Their Patients' Weight Loss Journeys Rather than encouraging their patients' weight loss journeys, physicians, perhaps unknowingly, inhibit their progress. Yoni Freedhoff expounds on the ways that physicians sabotage their patients.
  Medscape Diabetes & Endocrinology, July 11, 2023
• Can't Stop the Hyperbole About Diet Interventions The news proclaiming the success of the UK's diet-based protocol in weight mitigation in people with type 2 diabetes overexaggerates the findings. Yoni Freedhoff, MD, expounds on why it's misleading.
  Medscape Diabetes & Endocrinology, May 18, 2023
• Double Standards Continue in Antiobesity Meds Discourse Recent reports are criticizing researchers for not disclosing their funding when talking about new antiobesity medications. Dr Yoni Freedhoff argues that this is another form of weight bias.
  Medscape Diabetes & Endocrinology, April 12, 2023
• New Antiobesity Drugs Will Benefit Many. Is That Bad? New antiobesity medicines are being deemed too costly for insurers despite the success patients have had with losing weight and improving their health. Dr Yoni Freedhoff ponders why.
  Medscape Diabetes & Endocrinology, March 31, 2023
• What Happens When Newer Weight Loss Meds Are Stopped? Anti-obesity meds are a "game-changer" for many people with obesity, but what happens when people stop taking them? Dr Jaime Almandoz explains.
  Medscape Diabetes & Endocrinology, March 27, 2023
• Will New Guidelines Widen the Gap in Treating Kids' Obesity? The new AAP guidelines advocating for "aggressive" treatment in managing obesity in kids may only further widen the gap between the "haves and have-nots," argues Liliana Aguayo.
  Medscape Diabetes & Endocrinology, March 13, 2023
• Calories of Love: Grandparents Push Sugar on Grandkids A new study found grandparents are guilty of pushing sugary treats on their grandkids. Yoni Freedhoff shares his family's experience with sugar pushers and offers alternative treat recommendations.
  Medscape Diabetes & Endocrinology, February 24, 2023
• Weight Bias Affects Views of Kids' Obesity Recommendations New recommendations for "aggressive treatment" for children with obesity have sparked outrage among many. Dr Yoni Freedhoff says the extreme reaction doesn't surprise him but is unwarranted.
  Medscape Diabetes & Endocrinology, January 26, 2023
• Does Paying People to Lose Weight Work? Paying people with obesity to lose weight worked in a recent study, but Dr Yoni Freedhoff contends that it's not a long-term solution.
  Medscape Diabetes & Endocrinology, December 12, 2022
• How Much Exercise Will It Take to Burn Off? A recent initiative asks that prepared food labels include how much exercise it will take to burn off. Dr Yoni Freedhoff explains why this won't work.
  Medscape Diabetes & Endocrinology, December 02, 2022
• Managing Conversations About Weight in Non-White Patients Discussing obesity with patients of color provides unique challenges for healthcare providers. Jamy D. Ard, MD, offers advice on navigating these conversations.
  Medscape Diabetes & Endocrinology, October 18, 2022
• How Much Weight Does My Patient Need to Lose? Dr Donna Ryan discusses why we need to think of weight loss in terms of percentages, not pounds shed, and provides insight into how as little as a 5% loss can improve individual health.
  Medscape Diabetes & Endocrinology, August 24, 2022
• 'Stop Pretending' There's a Magic Formula to Weight Loss Dr Yoni Freedhoff explains that studies promoting short-term weight-loss programs don't really have any value as the programs are not sustainable.
  Medscape Diabetes & Endocrinology, August 17, 2022
• Do You Consider Medications to Treat Obesity? It's no longer acceptable to tell patients with obesity to "just try harder." Instead, Dr Robert F. Kushner counsels, it's time to consider medication for weight management.
  Medscape Diabetes & Endocrinology, August 02, 2022
• Pediatric Obesity Treatment Options As the numbers of children with obesity continues to increase, new and more effective treatments are available. Dr Justin Ryder reviews some of the options.
  Medscape Diabetes & Endocrinology, July 19, 2022
• Why Is Long-term Weight Loss So Difficult? Understanding the biologic and physiologic defense of body fat mass is essential to understanding weight regain and helping patients succeed with long-term maintenance of weight loss.
  Medscape Diabetes & Endocrinology, May 25, 2022